Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Patent
1995-06-15
1999-11-16
Allen, Marianne P.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
435325, 435356, 435357, 435358, 435365, C12N 1518, G01N 3300
Patent
active
059855851
DESCRIPTION:
BRIEF SUMMARY
BACKGROUND OF THE INVENTION
Throughout this application various publications are referred to by partial citations within parenthesis. Full citations for these publications may be found at the end of the specification immediately preceding the claims. The disclosures of these publications, in their entireties, are hereby incorporated by reference into this application in order to more fully describe the state of the art to which this invention pertains.
The subject invention of this application, DNA encoding a human serotonin receptor (5-HT.sub.4B) and uses thereof, refers to the "5-HT.sub.4B receptor" which has been renamed to the "5-HT.sub.7 receptor" by the "Serotonin Receptor Nomenclature Committee" of the IUPHAR. Thus, all claims herein directly or indirectly related to the 5-HT.sub.4B receptor and nucleic acid molecules encoding the 5-HT.sub.4B receptor are drawn to the 5-HT.sub.7 receptor and nucleic acid molecules encoding the 5-HT.sub.7 receptor also.
Primary amino acid sequence and signal transduction data are now published for four cloned 5-HT.sub.1 -like receptors, three cloned 5-HT.sub.2 receptors, and one 5-HT.sub.3 a receptor. Analysis of the sequence homology as well as the signal transduction pathways of these receptors leads to their grouping on the basis of these attributes: The 5-HT.sub.1 subfamily includes: 5-HT.sub.1A (Fargin, 1988; Kobilka, 1989), 5-HT.sub.1B /5-HT.sub.1D.beta. (Weinshank et al., 1991 and the rest), 5-HT.sub.1D.alpha. (Branchek et al. 1991; Hamblin and Metcalf, 1991; Weinshank et al., 1992), 5-HT.sub.1E (Levy et al., 1992; McAllister et al., 1992, Zgombick et al., 1992) and 5-HT.sub.1F (Adham et al, 1993). These subtypes share >50% transmembrane amino acid identity and couple to the inhibition of adenylate cyclase. The 5-HT.sub.2 family includes the 5-HT.sub.2 receptor (Pritchett et al., 1988), 5-HT.sub.1C (Julius et al., 1989) and 5-HT.sub.2F (Rat Stomach Fundus; Foguet et al., 1992; Kursar et al., 1992). These receptors share >70% amino acid identity and coupling to phosphoinositide hydrolysis. The 5-HT.sub.3 receptor has been shown to be a ligand-gated ion channel (Maricq et al., 1991). Heterogeneity of 5-HT.sub.3 receptors is controversial, although other ligand-gated ion channels display significant heterogeneity. Notably absent from this series are the 5-HT.sub.4 receptors. The second messenger coupling from tissue studies indicates activation of adenylate cyclase as a primary mode of signal transduction (Dumius et al., 1988; Bockaert et al., 1990). We report here the cloning of the first mammalian 5-HT receptor that couples to the stimulation of adenylate cyclase activity which we propose to name 5-HT.sub.4B. The pharmacological properties of this receptor indicate that it may be similar to a series of functionally defined 5-HT receptors described in the porcine vena cava (Trevethick et al., 1984), cat saphenous vein, coronary arteries [Cushing and Cohen, 1992, and several vascular dilatory effects (Mylecharane and Phillips, 1989). These receptors appear to underlie contractile and relaxant responses in isolated blood vessels indicating potential therapeutic benefit in angina, coronary artery disease, atherosclerosis, and possibly cerebral blood vessel disorders leading to stroke. The presence of this subtype in the CNS also indicates potential use in disorders of higher cognitive processes as well as control of autonomic function.
SUMMARY OF THE INVENTION
This invention provides an isolated nucleic acid molecule encoding a mammalian 5-HT.sub.4B receptor. In a preferred embodiment of this invention, the isolated nucleic acid encodes a human 5-HT.sub.4B receptor. In another embodiment of this invention, the nucleic acid molecule comprises a plasmid designated pcEXV-5-HT.sub.4B (ATCC Accession No. 75332).
This invention provides a nucleic acid probe comprising a nucleic acid molecule of at least 15 nucleotides capable of specifically hybridizing with a sequence included within the sequence of a nucleic acid molecule encoding a mammalian 5-HT.sub.4B rece
REFERENCES:
patent: 5155218 (1992-10-01), Weinshank et al.
patent: 5360735 (1994-11-01), Weinshank et al.
Meyerhof, W. et al., Dna and CELL Biology. 12(5):401-409, (1993).
Hen, R., TIPS, 13: 160-165, Apr. 1992.
NTIS Publication No. PB93-139335, Sibley, D. R., et al., Oct. 26, 1992.
Kobilka, B.K., et al., Nature 1987 329:75-79.
Dumuis, A., et al. Amer. Soc. Pharm. Exper. Ther. 1988 34: 880-887.
Bockaert, J. et al., Amer. Soc. Pharm. Exper. Ther. 1989 37:408-411.
Witz, P., et al., Proc. Natl. Acad. Sci. USA 1990 87:8940-8944.
New England BioLabs Catalog, 1990-1991, p. 48.
El Mestikawy, et al., Neurochemical Research 1991 16:(1): 1-10.
Weinshank, R. L., et al., Int. Acad. Biomed. Drug Res., Basel Karger 1992 1:1-12.
Roth, B.L., et al., J. Pharm. Exp. Ther. 1994 268(3):1403-1410.
Martin, G.R., et al., Proc. Brit. Pharm. Soc. Dec. 1994 p. 221.
Bard Jonathan A.
Branchek Theresa
Weinshank Richard L.
Allen Marianne P.
Synaptic Pharmaceutical Coorporation
White John P.
LandOfFree
Processes using a human serotonin receptor (5-HT.sub.4B) does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Processes using a human serotonin receptor (5-HT.sub.4B), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Processes using a human serotonin receptor (5-HT.sub.4B) will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1323089